Sign In
Buy FUSN
$13.26
+0 (+0%)
At Close: Sep 04, 2020
2 More Potential Biotech Buyout Targets
01:07pm, Monday, 25'th Mar 2024
M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance sheets, key patent expirations, and declining revenue from Covid related produ
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates
04:05pm, Wednesday, 20'th Mar 2024
Company recently announced definitive agreement to be acquired by AstraZeneca FPI-2265 Phase 2/3 registrational program for patients with metastatic castration-resistant prostate cancer (mCRPC) expect
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
02:25pm, Wednesday, 20'th Mar 2024
AstraZeneca (AZN) is set to acquire Fusion Biopharma (FUSN) for $21 per share in cash, along with a contingent value right of $3 per share, tied to a regulatory milestone.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Fusion Pharm
AstraZeneca is paying $2.4bn for Fusion Pharmaceuticals - but actually is it getting
08:51am, Tuesday, 19'th Mar 2024
AstraZeneca PLC (LSE:AZN) is acquiring Canada's Fusion Pharmaceuticals for $2.4 billion, in a bid to effectively 'keep up with Joneses' as it seeks to challenge Novartis, which is blazing a trail in t
Why Is Fusion Pharmaceuticals (FUSN) Stock Up 101% Today?
07:56am, Tuesday, 19'th Mar 2024
Fusion Pharmaceuticals (NASDAQ: FUSN ) stock is rocketing higher on Tuesday after the clinical-stage oncology company announced an acquisition deal with AstraZeneca (NASDAQ: AZN ). This has AstraZen
FUSN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Fusion Pharmaceuticals Inc. Is Fair to Shareholders
07:30am, Tuesday, 19'th Mar 2024
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) to AstraZeneca is fair to Fusion shareholders.
AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion
03:45am, Tuesday, 19'th Mar 2024
AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.
AstraZeneca to buy Fusion Pharma in $2.4bln deal
03:34am, Tuesday, 19'th Mar 2024
AstraZeneca PLC (LSE:AZN) is acquiring clinical-stage oncology group Fusion Pharmaceuticals in a $2.4 billion (£1.9 billion) deal. The offer represents a massive 126% premium to Nasdaq-listed Fusion'
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
03:00am, Tuesday, 19'th Mar 2024
Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities Fusion sharehold
HAMILTON, ON and BOSTON , March 5, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as prec
Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook
01:53am, Sunday, 03'rd Mar 2024
Fusion Pharmaceuticals is an oncology company focused on precision medicine and radiopharmaceuticals. The company's clinical candidates show promise in targeting and treating cancers with unmet needs.
Fusion (FUSN) to Report Q4 Earnings: Here's What to Expect
11:50am, Monday, 26'th Feb 2024
Investor focus is likely to be on updates regarding Fusion Pharmaceuticals' (FUSN) pipeline candidates on the fourth-quarter conference call.
Fusion Pharmaceuticals to Present at Upcoming March Investor Conferences
07:45am, Monday, 26'th Feb 2024
HAMILTON, ON and BOSTON , Feb. 26, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as prec
7 Low-Cost Call Options With High-Profit Potential
01:31pm, Monday, 19'th Feb 2024
Buying call options is a lot like (American) football. Sometimes, you run the ball up the middle.
